Sandra Nestler-Parr

Sandra Nestler-Parr is a seasoned executive in market access and value-based healthcare, currently serving as Senior Vice President of Value & Patient Access at BioCryst Pharmaceuticals, Inc. since September 2021. With extensive experience in the pharmaceutical industry, Sandra has held leadership roles including Vice President at BioCryst, Managing Director at Rare Access Ltd., and Head of Market Access Europe at Travere Therapeutics. Previous positions include Global Head of Market Access and Executive Director at Akcea Therapeutics, and Director of Market Access & Reimbursement at Advocate Healthcare Policy & Public Affairs. Sandra has a strong academic background with degrees from prestigious institutions, including a PhD from the University of London and an MSc from the London School of Economics.